Heart-Rate Variability Effects of β-Adrenoceptor Agonists (Xamoterol, Prenalterol, and Salbutamol) Assessed Nonlinearly with Scatterplots and Sequence Methods

Abstract

Full antagonists of the cardiac beta-adrenoceptor improve heart-rate variability (HRV) in humans; however, partial agonism at the beta2-adrenoceptor has been suggested to decrease HRV. We therefore studied the HRV effects of some partial agonists of the beta1- and beta2-adrenoceptors in normal volunteers. Under double-blind and randomised conditions (Latin square design), eight healthy volunteers received placebo; xamoterol, 200 mg (beta1-adrenoceptor partial agonist); prenalterol, 50 mg (beta1- and beta2-adrenoceptor partial agonist); salbutamol, 8 mg (beta2-adrenoceptor partial agonist); ICI 118,551, 25 mg (selective beta2-adrenoceptor antagonist); and combinations of each partial agonist with ICI 118,551. Single oral doses of medication (at weekly intervals) were administered at 22:30 h with HRV assessed from the overnight sleeping heart rates. HRV was determined by using standard time-domain summary statistics and two nonlinear methods, the Poincaré plot (scatterplot) and cardiac sequence analysis. On placebo, the sleeping heart rate decreased significantly, between 2 and 8 h after dosing. The heart rate with ICI 118,551 was unaltered. Xamoterol, prenalterol, and salbutamol increased the sleeping heart rate. ICI 118,551 blocked the heart-rate effects of salbutamol, attenuated those of prenalterol, but did not influence the xamoterol heart rate. The scatterplot (Poincaré) area was reduced by beta1-adrenoceptor (xamoterol), beta2-adrenoceptor (salbutamol), and combined beta1- and beta2-adrenoceptor (prenalterol) agonism. A reduction in scatterplot length followed salbutamol, prenalterol alone, and prenalterol in combination with ICI 118,551. The geometric analysis of the scatterplots allowed width assessment (i.e., dispersion) at fixed RR intervals. At higher heart rates (i.e., 25 and 50% of RR scatterplot length), dispersion was decreased after xamoterol, prenalterol, and prenalterol/ICI 118,551. Cardiac sequence analysis (differences between three adjacent beats; deltaRR vs. deltaRRn+1) assessed the short-term patterns of cardiac acceleration and deceleration; four patterns were identified: +/+ (a lengthening sequencing), +/- or -/+ (balanced sequences), and finally -/- (a shortening sequence). Cardiac acceleration or deceleration episodes (i.e., number of times deltaRR and deltaRRn+1 were altered in the same direction) were increased after salbutamol and prenalterol. In conclusion, partial agonism at either the cardiac beta1-adrenoceptor (xamoterol), beta2-adrenoceptor (salbutamol), and beta1- plus beta2-adrenoceptors (prenalterol) altered the autonomic balance toward sympathetic dominance in healthy volunteers; blockade of the beta2-adrenoceptor with the highly selective beta2-antagonist ICI 118,551 prevented the effects of salbutamol on HRV, attenuated the HRV effects of prenalterol, but had no effect on the actions of xamoterol. Agonism at both the beta1- and beta2-adrenoceptor reduced HRV in healthy subjects; the implications for the preventive use of the beta-adrenoceptor compounds in cardiovascular dis...

“In‐House” Data on the Outside—A Mobile Health Approach

“…With salbutamol administration, HR increased by 12.9 bpm on day 1 (in‐clinic), and by 11.8 bpm on day 3, and 5.4 bpm on day 5 (measured at home). These data were in keeping with reported observations of ~ 5–12 bpm . When examining the continuous data set beyond 6 hours (day 1), it was not possible to appreciate continuous separation between salbutamol and no treatment.…”

Heart rate variability in young patients with diabetes mellitus and healthy subjects explored by Poincaré and sequence plots

“…Briefly, a Poincaré plot is the scatterplot of current R-R interval against the R-R interval immediately preceding it and provides summary information about both overall and beat-to-beat HRV. The widths of Poincaré plot pattern at 10th, 25th, 50th, 75th and 90th percentiles of R-R intervals distribution -W10, W25, W50, W75 and W90were quantified according to Schechtman et al (1992) and Silke et al (1999). Quantitative analysis of the Poincaré plot ( Fig.…”

Short‐term effects of inhaled salbutamol on autonomic cardiovascular control in healthy subjects: a placebo‐controlled study

“…N, total number of identified spontaneous baroreceptor sequences Effects of inhaled salbutamol on cardiovascular autonomic control Stimulation of the b2-adrenoceptor further exerts important effects on autonomic cardiovascular control. Administration of salbutamol via the oral route has previously been shown to reduce overall heart rate variability and increase sympathetic components of HRV [44]. Only few reports, however, have investigated the effects of inhaled short acting b2 agonists on HRV.…”